|

US-sourced Keytruda® Clinical Trials

2 actively recruiting trials across 1 location

Also known as: pembrolizumab

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • mAbxience Research S.L.1
  • Shanghai Henlius Biotech1

Indications

  • Lung Cancer2
  • Cancer2
  • Non-Squamous Non-Small Cell Lung Cancer1
  • Renal Cell Carcinoma1
  • Melanoma1

Other1 trial

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
Phase 3

Glendale, California1 trial

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

Oncology Physicians Network (OPN) - Glendale

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.